Sarepta Therapeutics, Inc. (SRPT) stock
SRPTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3086% below fair value
$14.77−0.36 (-2.38%)
Close on Nov 17, 2026Market cap $1.56BP/E –Yield –
Sarepta Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Sarepta Therapeutics's price to book ratio was 1.2× on Nov 11, 2026, against 1.5× a year earlier. Over the last 5 years it ranged from 1.0× to 31.5×, with a median of 9.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.2× | −0.4 |
| 2025 | Dec 31, 2025 | 1.5× | −8.0 |
| 2024 | Dec 31, 2024 | 9.5× | −2.3 |
| 2023 | Dec 29, 2023 | 11.8× | −14.6 |
| 2022 | Dec 30, 2022 | 26.4× | +11.1 |
| 2021 | Dec 31, 2021 | 15.3× | +0.3 |
| 2020 | Dec 31, 2020 | 15.1× | +5.4 |
| 2019 | Dec 31, 2019 | 9.7× | −1.7 |
| 2018 | Dec 31, 2018 | 11.4× | +6.2 |
| 2017 | Dec 29, 2017 | 5.2× | +1.5 |
| 2016 | Dec 30, 2016 | 3.6× | −9.5 |
| 2015 | Dec 31, 2015 | 13.1× | +11.0 |
| 2014 | Dec 31, 2014 | 2.1× | −1.0 |
| 2013 | Dec 31, 2013 | 3.1× | −38.5 |
| 2012 | Dec 31, 2012 | 41.6× | +38.4 |
| 2011 | Dec 30, 2011 | 3.2× | – |
See a number that looks wrong?